Mesylate esters. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

K562 Cells Philadelphia Chromosome Cell Line, Tumor Cells, Cultured Cell Line Tumor Cells, Cultured Chromosomes, Human, Pair 9 Fibroblasts Skin Neoplastic Stem Cells Myeloid Progenitor Cells Orbit HL-60 Cells Liver Bone Marrow Stromal Cells Hematopoietic Stem Cells

Organisms2

Rats, Sprague-Dawley Rats, Wistar

Diseases36

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Mastocytosis, Systemic Dermatofibrosarcoma Fibromatosis, Aggressive Lichenoid Eruptions Nausea Leukemia, Myeloid, Accelerated Phase Primary Myelofibrosis Neoplasm, Residual Vomiting Recurrence Neutropenia Histiocytoma, Malignant Fibrous Disease Progression Scleroderma, Systemic Thrombocytopenia Graves Ophthalmopathy Fibrosis Anorexia Spinal Cord Neoplasms Leukemia Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm Metastasis Pulmonary Fibrosis Disease Models, Animal Nerve Sheath Neoplasms Myeloproliferative Disorders

Chemicals and Drugs129

Esters Benzamides Piperazines Pyrimidines Cholesterol Esters Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Ketones Receptor, Platelet-Derived Growth Factor alpha Furans Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor beta NG-Nitroarginine Methyl Ester Cholesterol Ester Transfer Proteins Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Carboxylic Ester Hydrolases Mesylates Pergolide Fenoldopam Tetradecanoylphorbol Acetate Enzyme Inhibitors Pefloxacin Benzoxazines Delavirdine Receptors, Platelet-Derived Growth Factor Naphthalenes Tubulin Modulators Pralidoxime Compounds Quinolizines Nelfinavir Proto-Oncogene Proteins c-sis Gabexate Protein Kinase C Pyrroles Morpholines Antimitotic Agents Indoles Cannabinoids Phorbols RNA, Messenger Cannabinoid Receptor Agonists Waxes Ergolines Dihydroergotoxine Sterol Esterase Harringtonines Bromocriptine mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Doxazosin Rifabutin Dexamethasone Cholesterol Fatty Acids Phenylethyl Alcohol Interferon-alpha Lipid Peroxides Receptors, Glucocorticoid Platelet-Derived Growth Factor Caffeic Acids Esterases Free Radical Scavengers Piperidines Thiazoles Receptors, Cannabinoid Lipoproteins, HDL STAT5 Transcription Factor Nitric Oxide Phentolamine Hydroxyurea Receptor, Cannabinoid, CB1 Carboxylesterase Stem Cell Factor Pyrazoles Carrier Proteins Adrenergic alpha-Antagonists Cannabinoid Receptor Antagonists Antiemetics Affinity Labels Lipase Milk Proteins Tosylarginine Methyl Ester Diglycerides Camptothecin Lipoproteins, LDL Triglycerides Antineoplastic Agents, Phytogenic Nitric Oxide Synthase Oncogene Proteins, Fusion Dronabinol Vitamin A ATP-Binding Cassette Transporters Topotecan Neoplasm Proteins Acyl Coenzyme A Prodrugs Naphthyridines Acyltransferases Lipoproteins Phthalic Acids Pyridines Lactams, Macrocyclic Iron Chelating Agents Antigens, CD34 Phospholipids Benzoquinones Drug Combinations Carboxylic Acids Cyclohexanols P-Glycoprotein Lipids Organosilicon Compounds Arginine Oleic Acids Imidazoles src-Family Kinases Glycoproteins Succinimides Glycerides Triamcinolone Acetonide HIV Protease Inhibitors Cannabinoid Receptor Modulators Alcohols Bleomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Cytogenetic Analysis Treatment Outcome Drug Approval Remission Induction Administration, Oral Chromatography, High Pressure Liquid Disease-Free Survival Drug Administration Schedule Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Treatment Failure Salvage Therapy Blotting, Western Antineoplastic Combined Chemotherapy Protocols Inhibitory Concentration 50 Prognosis In Situ Hybridization, Fluorescence Immunohistochemistry Retreatment Maximum Tolerated Dose Survival Rate Chromatography, Gas Mass Spectrometry Follow-Up Studies Drug Stability Chromatography, Thin Layer Blood Cell Count Area Under Curve Neoadjuvant Therapy Combined Modality Therapy Drug Screening Assays, Antitumor Infusions, Intravenous Transplantation, Homologous Transfection Disease Models, Animal Magnetic Resonance Spectroscopy Positron-Emission Tomography Gas Chromatography-Mass Spectrometry Double-Blind Method

Phenomena and Processes34

Drug Resistance, Neoplasm Genes, abl Dose-Response Relationship, Drug Philadelphia Chromosome Time Factors Kinetics Phosphorylation Apoptosis Drug Synergism Esterification Molecular Structure Hydrolysis Mutation Signal Transduction Cell Proliferation Enzyme Activation Cell Survival Inhibitory Concentration 50 Stereoisomerism Chromosomes, Human, Pair 9 Gene Expression Regulation, Leukemic Maximum Tolerated Dose Drug Interactions Blood Cell Count Area Under Curve Down-Regulation Substrate Specificity G0 Phase Structure-Activity Relationship Gene Expression Tissue Distribution Cell Division Transfection Hydrogen-Ion Concentration

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science2

Survival Rate Molecular Sequence Data

Health Care9

Treatment Outcome Disease-Free Survival United States Food and Drug Administration Survival Analysis Treatment Failure Survival Rate Follow-Up Studies Area Under Curve Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Esters Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Cholesterol Esters Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Ketones Receptor, Platelet-Derived Growth Factor alpha Furans Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta NG-Nitroarginine Methyl Ester Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Cytogenetic Analysis Drug Resistance, Neoplasm Genes, abl Cholesterol Ester Transfer Proteins Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Gastrointestinal Neoplasms K562 Cells Carboxylic Ester Hydrolases Mesylates Dose-Response Relationship, Drug Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Pergolide Treatment Outcome Philadelphia Chromosome Fenoldopam Tetradecanoylphorbol Acetate Drug Approval Enzyme Inhibitors Remission Induction Pefloxacin Benzoxazines Delavirdine Mastocytosis, Systemic Receptors, Platelet-Derived Growth Factor Naphthalenes Dermatofibrosarcoma Administration, Oral Tubulin Modulators Cell Line, Tumor Pralidoxime Compounds Time Factors Cells, Cultured Quinolizines Nelfinavir Kinetics Proto-Oncogene Proteins c-sis Phosphorylation Gabexate Fibromatosis, Aggressive Protein Kinase C Pyrroles Chromatography, High Pressure Liquid Morpholines Apoptosis Antimitotic Agents Indoles Drug Synergism Esterification Molecular Structure Disease-Free Survival Cannabinoids Phorbols RNA, Messenger Cannabinoid Receptor Agonists Waxes Ergolines Dihydroergotoxine Drug Administration Schedule Lichenoid Eruptions Sterol Esterase Harringtonines Bromocriptine Cell Line Nausea Hydrolysis United States Food and Drug Administration mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Mutation Leukemia, Myeloid, Accelerated Phase Signal Transduction Doxazosin Cell Proliferation Rifabutin Dexamethasone Cholesterol

No FAQ available that match "mesylate esters"